Wells Fargo & Company »

Astria Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Astria Therapeutics (ATXS) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Astria Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Astria Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Astria Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $206k 27k 7.68
2023-09-30 $41k 5.4k 7.46
2023-06-30 $88k 11k 8.33
2022-12-31 $1.3k 87 14.89
2022-09-30 $1.0k 60 16.67
2022-06-30 $0 64 0.00
2022-03-31 $0 58 0.00
2021-12-31 $0 58 0.00
2021-09-30 $1.0k 57 17.54